Evidence map›Paper›PMID 40378983›Full record

Trial reportClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association2025

A Pilot Randomized Control Trial to Assess the Adjunctive Effect of Diet on Response to Advanced Therapies in Patients With Ulcerative Colitis.

Oriana M Damas, Morgan Leo, Niurka Colina, Michael Mijares, Irina Fernandez, Julia McALeavy, Isabella Hernandez, Cristiana Assumpção-Mengarelli, Luis Garces, Maria A Quintero and 9 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Oriana M DamasDivision of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine, Miami, Florida. Electronic address: odamas@med.miami.edu.
Morgan LeoDivision of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine, Miami, Florida.
Niurka ColinaDivision of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine, Miami, Florida.
Michael MijaresDivision of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine, Miami, Florida.
Irina FernandezDivision of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine, Miami, Florida.
Julia McALeavyDivision of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine, Miami, Florida.
Isabella HernandezDivision of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine, Miami, Florida.
Cristiana Assumpção-MengarelliDivision of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine, Miami, Florida.
Luis GarcesDivision of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine, Miami, Florida.
Maria A QuinteroDivision of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine, Miami, Florida.
Mailenys OrtegaDivision of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine, Miami, Florida.
Norma SolisDivision of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine, Miami, Florida.
Cristal BatistaDivision of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine, Miami, Florida.
Bety De La TorreDivision of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine, Miami, Florida.
Maria T AbreuDivision of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine, Miami, Florida.
Amar R DeshpandeDivision of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine, Miami, Florida.
David H KermanDivision of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine, Miami, Florida.
Siobhan ProksellDivision of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine, Miami, Florida.
Yuguang BanSylvester Comprehensive Cancer Center, University of Miami Health System, Miami, Florida; Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, Florida.

Funding

The impact of diet patterns and PUFA-related polymorphisms on ulcerative colitis in HispanicsK23DK117054 · NIDDK · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI DAMAS, ORIANA MAZORRA · 2019 to 2023
$1.0M
NIDDK NIH HHS K23 DK117054
6 · The paper itself

Abstract

BACKGROUND &

aimsDiet may influence ulcerative colitis (UC), but its impact on medication response remains unclear. We examined whether two 5-day cycles of a low-calorie, plant-based (LC-PB), fasting-mimicking diet could improve UC response to medications in a controlled trial.

methodsAdults with active UC starting advanced therapies were randomized to an LC-PB diet + therapy or a control diet + therapy. The LC-PB diet provided 1090 kcal on day 1 and 725 kcal on days 2-5. The Simple Clinical Colitis Activity Index (SCCAI) was assessed at baseline and week 8. The study, planned for 60 patients, ended early due to COVID-19. The primary endpoint was clinical response (week 8, SCCAI decrease ≥3). Secondary outcomes were clinical improvement (change in SCCAI from baseline), steroid tapering, C-reactive protein, serum amyloid A (SAA), and fecal calprotectin.

resultsOf 32 enrolled patients, 23 completed the study. In the intention-to-treat analysis, 57% (n = 8 of 14) in the LC-PB arm achieved clinical response by week 8 vs 35% (n = 6 of 17) in control arm (P = .11). Secondary analyses indicated greater clinical improvement, measured as continuous SCCAI, in the LC-PB group compared with the control group (P = .039). The LC-PB group had better SCCAI subscores (ie, urgency, well-being), had reductions in SAA, and were tapered off steroids compared with the control group. Mean C-reactive protein and fecal calprotectin decreased more in the LC-PB group, but results were not significant. There were no serious adverse events relating to the diet and no weight loss.

conclusionsThe LC-PB diet did not improve clinical response to medications. However, it led to clinical improvement, steroid tapering, and reduced SAA. As results were limited by sample size, larger studies are needed.

Indexed as

Caloric RestrictionColitis, UlcerativeAdultAgedC-Reactive ProteinFecesFemaleHumansLeukocyte L1 Antigen ComplexMaleMiddle AgedPilot ProjectsSerum Amyloid A ProteinTreatment OutcomeC-Reactive ProteinLeukocyte L1 Antigen ComplexSerum Amyloid A ProteinDietFasting Mimicking DietIntermittent FastingPlant-BasedUlcerative Colitis

Identifiers

PMID40378983
PMCPMC12354011

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.